share_log

西南证券:医药行业仍有结构性机会

Securities Times ·  Apr 7 20:59

证券时报网讯,西南证券研报指出,在海外宏观降息预期下,叠加政策、估值、基本面三个维度,医药行业仍有结构性机会。1)创新+出海仍是看好的思路;2)医疗反腐后,关注院内医疗刚性需求;3)关注“低估值+业绩反转”个股。此外,今年减肥药和AI医疗仍有主题投资性机会。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment